{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:06:54Z","timestamp":1787317614936,"version":"build-2736575974"},"reference-count":51,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1476-4431.2010.00526.x","type":"journal-article","created":{"date-parts":[[2010,3,20]],"date-time":"2010-03-20T20:18:02Z","timestamp":1269116282000},"page":"237-243","source":"Crossref","is-referenced-by-count":67,"title":["Administration of 5% human serum albumin in critically ill small animal patients with hypoalbuminemia: 418 dogs and 170 cats (1994-2008)"],"prefix":"10.1111","volume":"20","author":[{"given":"Fabio","family":"Vigan\u00f3","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Perissinotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina R. F.","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB1","first-page":"107","author":"McGrotty","year":"2006"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB2","doi-asserted-by":"crossref","unstructured":"2.\u2002 Quinlan GJ , Martin GS , Evans TW. Albumin: biochemical properties and therapeutic potential. Hepatology 2005; 41 (6):1211-1219.","DOI":"10.1002\/hep.20720"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB3","doi-asserted-by":"crossref","unstructured":"3.\u2002 Haller C. Hypoalbuminemia in renal failure: pathogenesis and therapeutic considerations. Kidney Blood Press Res 2005; 28:307-310.","DOI":"10.1159\/000090185"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB4","doi-asserted-by":"crossref","unstructured":"4.\u2002 Mazzaferro EM , Rudloff E , Kirby R. The role of albumin replacement in the critically ill veterinary patient. J Vet Emerg Crit Care 2002; 12 (2):113-124.","DOI":"10.1046\/j.1435-6935.2002.00025.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB5","doi-asserted-by":"crossref","unstructured":"5.\u2002 Mathews KA , Barry M. The use of 25% human serum albumin: outcome and efficacy in raising serum albumin and systemic blood pressure in critically ill dogs and cats. J Vet Emerg Crit Care 2005; 15 (2):110-118.","DOI":"10.1111\/j.1476-4431.2005.00141.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB6","doi-asserted-by":"crossref","unstructured":"6.\u2002Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomized controlled trials. Br Med J 1998; 317:235-240.","DOI":"10.1136\/bmj.317.7153.235"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB7","doi-asserted-by":"crossref","unstructured":"7.\u2002 Dubois MJ , Orellana-Jimenez C , Melot C , et al. Albumin administration improves organ function in critically ill hypoalbuminemic patients: a prospective, randomized, controlled, pilot study. Crit Care Med 2006; 34:2536-2540.","DOI":"10.1097\/01.CCM.0000239119.57544.0C"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB8","doi-asserted-by":"crossref","unstructured":"8.\u2002SAFE Study Investigators, Finfer S , Bellomo R , et al. Effect of baseline serum albumin concentration on outcome of resuscitation with albumin or saline in patients in intensive care units: analysis of data from the saline versus albumin fluid evaluation (SAFE) study. Br Med J 2006; 333 (7577):1044, doi:.","DOI":"10.1136\/bmj.38985.398704.7C"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB9","doi-asserted-by":"crossref","unstructured":"9.\u2002 Goldwasser P , Feldman J. Association of serum albumin and mortality risk. J Clin Epidemiol 1997; 50:693-703.","DOI":"10.1016\/S0895-4356(97)00015-2"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB10","first-page":"263","volume-title":"BSAVA Manual of Canine and Feline Hematology and Transfusion Medicine","author":"Abrams-Ogg","year":"2000"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB11","doi-asserted-by":"crossref","unstructured":"11.\u2002 Martin GS , Mangialardi RJ , Wheeler AP , et al. Albumin and furosemide therapy in hypoproteinemic patients with acute lung injury. Crit Care Med 2002; 30:2175-2182.","DOI":"10.1097\/00003246-200210000-00001"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB12","doi-asserted-by":"crossref","unstructured":"12.\u2002 Vincent JL. Issues in contemporary fluid management. Crit Care 2000; 4 (2):S1-S2.","DOI":"10.1186\/cc964"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB13","doi-asserted-by":"crossref","unstructured":"13.\u2002 Wang H , Ma S. The cytokine storm and factors determining the sequence and severity of organ dysfunction in multiple organ dysfunction syndrome. Am J Emerg Med 2008; 26 (6):711-715.","DOI":"10.1016\/j.ajem.2007.10.031"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB14","doi-asserted-by":"crossref","unstructured":"14.\u2002 Hedin A , Hahan RG. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci 2005; 108:217-224.","DOI":"10.1042\/CS20040303"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB15","doi-asserted-by":"crossref","unstructured":"15.\u2002 Zhang S , Li H , Ma L , et al. Polynitroxyl-albumin (PNA) plus tempol attenuate lung capillary leak elicited by prolonged intestinal ischemia and reperfusion. Free Radic Biol Med 2000; 29 (1):42-50.","DOI":"10.1016\/S0891-5849(00)00295-1"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB16","doi-asserted-by":"crossref","unstructured":"16.\u2002 Mathews KM. Various types of parenteral fluids and their indications. Vet Clin North Am Small Anim Pract 1998; 28 (3):498-504.","DOI":"10.1016\/S0195-5616(98)50052-6"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB17","first-page":"621","volume-title":"Fluid Therapy in Small Animal Practice","author":"Hughes","year":"2006"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB18","unstructured":"18.\u2002 Smiley LE. The use of hetastarch for plasma expansion. Probl Vet Med 1992; 4 (4):652-667."},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB19","doi-asserted-by":"crossref","unstructured":"19.\u2002 Schierhout G , Roberts I. Fluid resuscitation with colloid or crystalloid solution in critically ill patients: a systematic review of randomised trials. Br Med J 1998; 316:361-364.","DOI":"10.1136\/bmj.316.7136.961"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB20","doi-asserted-by":"crossref","unstructured":"20.\u2002 Mishler JM. Synthetic plasma volume expanders: their pharmacology, safety and clinical efficacy. Clin Haematol 1984; 13:75-92.","DOI":"10.1016\/S0308-2261(18)30034-1"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB21","doi-asserted-by":"crossref","unstructured":"21.\u2002 Vercueil A , Grocott MP , Mythen MG. Physiology, pharmacology, and rationale for colloid administration for the maintenance of effective hemodynamic stability in critically ill patients. Transfus Med Rev 2005; 19 (2):93-109.","DOI":"10.1016\/j.tmrv.2004.11.006"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB22","doi-asserted-by":"crossref","unstructured":"22.\u2002 Kuper M , Gunning MP , Halder S , et al. The short-term effect of hyperoncotic albumin, given alone or with furosemide, on oxygenation in sepsis-induced acute respiratory distress syndrome. Anaesthesia 2007; 62 (3):259-263.","DOI":"10.1111\/j.1365-2044.2007.04941.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB23","doi-asserted-by":"crossref","unstructured":"23.\u2002 Greissman A , Silver P , Nimkoff L , et al. Albumin bolus administration versus continuous infusion in critically ill hypoalbuminemic pediatric patients. Intensive Care Med 1996; 22 (5):495-499.","DOI":"10.1007\/BF01712175"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB24","doi-asserted-by":"crossref","unstructured":"24.\u2002 Martin GS , Moss M , Wheeler AP , et al. A randomized controlled trial of furosemide with or without albumin in hypoproteinemic patients with acute lung injury. Crit Care Med 2005; 33 (8):1681-1687.","DOI":"10.1097\/01.CCM.0000171539.47006.02"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB25","doi-asserted-by":"crossref","unstructured":"25.\u2002 Runyon BA. Management of adult patients with ascites caused by cirrhosis. Hepatology 1998; 27:264-272.","DOI":"10.1002\/hep.510270139"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB26","doi-asserted-by":"crossref","unstructured":"26.\u2002 Perel P , Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2007; (4):1-65.","DOI":"10.1002\/14651858.CD000567.pub3"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB27","doi-asserted-by":"crossref","unstructured":"27.\u2002 P\u00e9ron JM , Bureau C , Gonzales L , et al. Treatment of hepatorenal syndrome as defined by the international ascites club by albumin and furosemide infusion according to the central venous pressure: a prospective pilot study. Am J Gastroenterol 2005; 100 (12):2702-2707.","DOI":"10.1111\/j.1572-0241.2005.00271.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB28","doi-asserted-by":"crossref","unstructured":"28.\u2002 Vincent JL , Navicks R , Wilkes M. Morbidity in hospitalized patients receiving human albumin: a meta-analysis of randomized, controlled trials. Crit Care Med 2004; 32 (10):2029-2038.","DOI":"10.1097\/01.CCM.0000142574.00425.E9"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB29","doi-asserted-by":"crossref","unstructured":"29.\u2002 Qiao R , Siflinger-Birnboim A , Tiruppathi C , et al. Albumin and Ricinus communis agglutinin decrease endothelial permeability via interactions with matrix. Am J Physiol Cell Physiol 1993; 265:C439-C446.","DOI":"10.1152\/ajpcell.1993.265.2.C439"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB30","doi-asserted-by":"crossref","unstructured":"30.\u2002 Ramirez-Vick J , Vargas FF. Albumin modulation of paracellular permeability of pig vena caval endothelium shows specificity for pig albumin. Am J Physiol Heart Circ Physiol 1993; 264:H1382-H1387.","DOI":"10.1152\/ajpheart.1993.264.5.H1382"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB31","doi-asserted-by":"crossref","unstructured":"31.\u2002 Soni N. Lessons from meta-analysis: the case of albumin. Transfus Altern Transfus Med 2001; 3 (4):6-13.","DOI":"10.1111\/j.1778-428X.2001.tb00039.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB32","first-page":"377","volume-title":"Fluid Therapy in Small Animal Practice","author":"Mathews","year":"2006"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB33","doi-asserted-by":"crossref","unstructured":"33.\u2002 Kheirabadi BS , Crissey JM , Deguzman R , et al. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. J Trauma 2008; 64 (5):1218-1229.","DOI":"10.1097\/TA.0b013e31816c5c6c"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB34","doi-asserted-by":"crossref","unstructured":"34.\u2002 Martin LG , Luther TY , Alperin DC , et al. Serum antibodies against human albumin in critically ill and healthy dogs. J Am Vet Med Assoc 2008; 232 (7):1004-1009.","DOI":"10.2460\/javma.232.7.1004"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB35","doi-asserted-by":"crossref","unstructured":"35.\u2002 Trow AV , Rozanski EA , deLaforcade A , et al. Evaluation of human albumin in critically ill dogs: 73 cases (2003-2006). J Am Vet Med Assoc 2008; 233 (4):607-612.","DOI":"10.2460\/javma.233.4.607"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB36","doi-asserted-by":"crossref","unstructured":"36.\u2002 Francis AH , Martin LG , Haldorson GJ , et al. Adverse reactions suggestive of type III hypersensitivity in six healthy dogs given human albumin. J Am Vet Med Assoc 2007; 230 (6):873-879.","DOI":"10.2460\/javma.230.6.873"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB37","doi-asserted-by":"crossref","unstructured":"37.\u2002 Cohn LA , Kerl ME , Lenox CE , et al. Response of healthy dogs to infusion of human serum albumin. Am J Vet Res 2007; 68 (6):657-663.","DOI":"10.2460\/ajvr.68.6.657"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB38","first-page":"1055","volume-title":"Textbook of Critical Care","author":"Falk","year":"1989"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB39","doi-asserted-by":"crossref","unstructured":"39.\u2002 Hiltebrand LB , Kimberger O , Arnberger M , et al. Crystalloids versus colloid for goal-directed fluid therapy in major surgery. Crit Care 2009; 13 (2):1-13.","DOI":"10.1186\/cc7761"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB40","unstructured":"40.\u2002 Rudloff E , Kirby R. The critical need for colloids: administering colloids effectively. Comp Cont Ed Pract Vet 1998; 20 (1):27-43."},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB41","doi-asserted-by":"crossref","unstructured":"41.\u2002 Logan JC , Callan MB , Drew K , et al. Clinical indications for use of fresh frozen plasma in dogs: 74 dogs (October through December 1999). J Am Vet Med Assoc 2001; 218:1449-1455.","DOI":"10.2460\/javma.2001.218.1449"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB42","doi-asserted-by":"crossref","unstructured":"42.\u2002 Hughes D. Fluid therapy with artificial colloids: complications and controversies. Vet Anaesth Analg 2001; 28:111-118.","DOI":"10.1046\/j.1467-2995.2001.00023.x"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB43","first-page":"189","volume-title":"The Veterinary ICU Book","author":"Green","year":"2002"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB44","first-page":"838","volume-title":"Schalm's Veterinary Hematology","author":"Brooks","year":"2000"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB45","doi-asserted-by":"crossref","unstructured":"45.\u2002 Yamaya Y , Niizeki K , Kim J , et al. Anaphylactoid response to optison\u00ae and its effects on pulmonary function in two dogs. J Vet Med Sci 2004; 66 (11):1429-1432.","DOI":"10.1292\/jvms.66.1429"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB46","unstructured":"46.\u2002 Vincent JL , Wilkes MM , Navickis RJ. Safety of human albumin-serious adverse events reported worldwide in 1998-2000. Br J Anaesth 2003; 91 (5):625-630."},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB47","first-page":"904","volume-title":"Schalm's Veterinary Hematology","author":"Modiano","year":"2000"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB48","first-page":"941","volume-title":"Schalm's Veterinary Hematology","author":"Zoran","year":"2000"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB49","doi-asserted-by":"crossref","unstructured":"49.\u2002 Azoulay E , Delclaux C. Is there a place for granulocyte colony-stimulating factor in non-neutropenic critically ill patients? Intensive Care Med 2004; 30 (1):10-17.","DOI":"10.1007\/s00134-003-2049-8"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB50","doi-asserted-by":"crossref","unstructured":"50.\u2002 Schmitz D , Wilsenack K , Lendemanns S , et al. \u03b2-adrenergic blockade during systemic inflammation: impact on cellular immune functions and survival in a murine model of sepsis. Resuscitation 2007; 72 (2):286-294.","DOI":"10.1016\/j.resuscitation.2006.07.001"},{"key":"10.1111\/j.1476-4431.2010.00526.x-BIB51","doi-asserted-by":"crossref","unstructured":"51.\u2002 Siegel JH , Fabian M , Smith JA , et al. Oxygen debt criteria quantify the effectiveness of early partial resuscitation after hypovolemic hemorrhagic shock. J Trauma 2003; 54 (5):862-880.","DOI":"10.1097\/01.TA.0000066186.97206.39"}],"container-title":["Journal of Veterinary Emergency and Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1476-4431.2010.00526.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1476-4431.2010.00526.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T21:54:43Z","timestamp":1635112483000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1476-4431.2010.00526.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":51,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1476-4431.2010.00526.x","relation":{},"ISSN":["1479-3261","1476-4431"],"issn-type":[{"value":"1479-3261","type":"print"},{"value":"1476-4431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}